CP and myeloid sarcoma: Pharmacologic manipulation of the plexus with natalizumab prevented further enlargement, opening the perspective that CP dynamics may be a useful MRI marker of disease activity in early MS, while it may not be helpful in long-standing MS (SPMS) [23,39].